{"nct_id":"NCT00639002","title":"A Study to Determine the Effect and Safety of an Oral Janus Kinase 2 (JAK2)-Inhibitor (Ruxolitinib; INBC018424) in Patients With Multiple Myeloma","status":"COMPLETED","status_verified_date":"2018-01","start_date":"2008-03","start_date_type":null,"primary_completion_date":"2010-07","primary_completion_date_type":"ACTUAL","completion_date":"2010-07","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["INCY"]}